Ultraviolet Light Therapy for Systemic Lupus Erythematosus
Phase 2
- Conditions
- Systemic Lupus Erythematosus
- Registration Number
- NCT00004375
- Lead Sponsor
- National Center for Research Resources (NCRR)
- Brief Summary
OBJECTIVES:
I. Evaluate the mechanisms of ultraviolet A-1 light therapy in patients with systemic lupus erythematosus and normal controls.
- Detailed Description
PROTOCOL OUTLINE:
Treatment with ultraviolet A-1 light is administered 5 days a week for 6 weeks, at the lowest dose or frequency required to maintain a response. The dose and frequency are progressively decreased over the next 9 weeks.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (2)
General Clinical Research Center and Charity Hospital (University of Louisiana)
🇺🇸New Orleans, Louisiana, United States
Alton Ochsner Medical Foundation Hospital
🇺🇸New Orleans, Louisiana, United States